CLINICAL_TRIALS
trial_result
· 2015-03-26
Clinical Trial Update: A Retrospective Real World Analysis Of Sutent In Patients With Metastatic Renal Cell Carcinoma In Community And Academic Centers To Assess The Impact Of Dose Variation On Duration Of Response And Overall Survival
Summary
A completed retrospective real-world study of sunitinib in metastatic renal cell carcinoma examines how dose variation affects duration of response and overall …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Metastatic Renal Cell Carcinoma | Status: COMPLETED | Results posted: 2015-03-26